Skip to content
Thursday, November 5, 2026 Market moodBearish−18.4
Sign in
GlideslopeGlideslopeGlideslope AI-powered market news
GlideslopeGlideslopeGlideslope
Market mood−18.4
Breaking
CNBC TOP STORIES Stock futures fall after Nasdaq correction; Japan's Nikkei 225 enters bear market: Live u… Bearish CBS NEWS Dolly Parton's estate moves to dismiss lawsuit against nephew Bearish CBS MONEY WATCH Why markets experienced massive tech sell-off Neutral BUSINESS INSIDER Thinking Machines Lab is closing in on a new $5 billion funding round at a $40 billion va… Neutral THE VERGE OpenAI is stepping back from NDAs for data center projects Neutral CBS NEWS Hegseth vows to continue war with Iran amid bipartisan impeachment threats Bearish THE GUARDIAN US NEWS US elections 2026 live: Democrats exceed 250 House seats as blue wave sweeping Congress g… Strong Bullish CBS NEWS USPS employee in custody after allegedly shooting 2 coworkers in Iowa post office Bearish COINTELEGRAPH Core Scientific to quit Bitcoin mining by year-end as AI business surges Strong Bullish NPR BUSINESS Fears about an AI crackdown after midterms sparks a $2 trillion rout in tech stocks Bearish NEW YORK POST BUSINESS Anthropic’s IPO timing threatened by AI backlash, historic tech rout Pessimistic TECHCRUNCH The New York Times reportedly in talks to buy Letterboxd for $330 million Neutral BBC BUSINESS The engine parts that 'fight the laws of the universe' Neutral THE GUARDIAN WORLD NEWS Slashing number of police forces in England and Wales is only option, says Met chief Bearish BBC BUSINESS 'I was asked if I was a crier': Your worst job interviews revealed Bearish CNBC TOP STORIES Costco is taking aim at its May record high — how it got here and where's it going Strong Bullish MARKET WATCH Cloudflare’s stock mounts a big comeback after fastest sales surge in nearly 4 years Strong Bullish MARKET WATCH Here are the 2027 capital-gains tax rates for each income level Strong Bullish THE VERGE The New York Times is in talks to buy Letterboxd for around $330 million Neutral ECONOMIST FINANCE ECONOMICS Markets realise they hate America’s blue wave Strong Bullish CNBC TOP STORIES Stock futures fall after Nasdaq correction; Japan's Nikkei 225 enters bear market: Live u… Bearish CBS NEWS Dolly Parton's estate moves to dismiss lawsuit against nephew Bearish CBS MONEY WATCH Why markets experienced massive tech sell-off Neutral BUSINESS INSIDER Thinking Machines Lab is closing in on a new $5 billion funding round at a $40 billion va… Neutral THE VERGE OpenAI is stepping back from NDAs for data center projects Neutral CBS NEWS Hegseth vows to continue war with Iran amid bipartisan impeachment threats Bearish THE GUARDIAN US NEWS US elections 2026 live: Democrats exceed 250 House seats as blue wave sweeping Congress g… Strong Bullish CBS NEWS USPS employee in custody after allegedly shooting 2 coworkers in Iowa post office Bearish COINTELEGRAPH Core Scientific to quit Bitcoin mining by year-end as AI business surges Strong Bullish NPR BUSINESS Fears about an AI crackdown after midterms sparks a $2 trillion rout in tech stocks Bearish NEW YORK POST BUSINESS Anthropic’s IPO timing threatened by AI backlash, historic tech rout Pessimistic TECHCRUNCH The New York Times reportedly in talks to buy Letterboxd for $330 million Neutral BBC BUSINESS The engine parts that 'fight the laws of the universe' Neutral THE GUARDIAN WORLD NEWS Slashing number of police forces in England and Wales is only option, says Met chief Bearish BBC BUSINESS 'I was asked if I was a crier': Your worst job interviews revealed Bearish CNBC TOP STORIES Costco is taking aim at its May record high — how it got here and where's it going Strong Bullish MARKET WATCH Cloudflare’s stock mounts a big comeback after fastest sales surge in nearly 4 years Strong Bullish MARKET WATCH Here are the 2027 capital-gains tax rates for each income level Strong Bullish THE VERGE The New York Times is in talks to buy Letterboxd for around $330 million Neutral ECONOMIST FINANCE ECONOMICS Markets realise they hate America’s blue wave Strong Bullish
CBS Money Watch · Jun 18, 2025 8:31 PM EDT Not market news

FDA approves HIV prevention drug taken as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained HIV negative.

FDA approves HIV prevention drug taken as twice-yearly injection
Image CBS Money Watch

AI brief

Pulse reads the full article
What happened
Why it matters
What to watch

Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.

Sign in to read the brief
● MACRO ANALYST

Apex+

Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.

LOG IN / SUBSCRIBE